Nuclear G-protein-coupled receptors as putative novel pharmacological targets

R Ribeiro-Oliveira, M Vojtek, S Gonçalves-Monteiro… - Drug Discovery …, 2019 - Elsevier
Highlights•Complete and active GPCRs signaling systems are also found in
nucleus.•Nuclear GPCRs trigger similar or distinct events than cell surface counterparts.• …

Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway

YG Jang, RE Go, KA Hwang, KC Choi - The Journal of steroid biochemistry …, 2019 - Elsevier
Prostate cancer (PCa) is one of the most common malignancies and the second most
common cause of cancer-related deaths in men world-wide and is known to be affected by …

Hypoxia-induced cancer stemness acquisition is associated with CXCR4 activation by its aberrant promoter demethylation

N Kang, SY Choi, BN Kim, CD Yeo, CK Park, YK Kim… - BMC cancer, 2019 - Springer
Background A hypoxic microenvironment leads to an increase in the invasiveness and the
metastatic potential of cancer cells within tumors via the epithelial-mesenchymal transition …

Overexpressed receptors and proteins in lung cancer

B Gorain, SK Bhattamishra, H Choudhury… - … -Based Targeted Drug …, 2019 - Elsevier
The worldwide prevalence of lung cancer is amongst the greatest of all cancers, and deaths
due to lung cancer are the highest. Current researches are focusing on a molecular …

Antitumor activity of cell‐penetrant kinin B1 receptor antagonists in human triple‐negative breast cancer cells

C Dubuc, M Savard, V Bovenzi… - Journal of Cellular …, 2019 - Wiley Online Library
High nuclear expression of G protein‐coupled receptors, including kinin B1 receptors (B1R),
has been observed in several human cancers, but the clinical significance of this is …

[PDF][PDF] The prognostic value of CXCR4, MMP-2 and MMP-9 in tongue squamous carcinoma

FI Ciucă, PC Mărăşescu, M Matei… - Rom J Morphol …, 2019 - researchgate.net
Currently, tongue squamous cancer appears to be more frequent, especially among adults
under the age of 45. Approximately 50% of these patients are diagnosed late, with clinically …

Glycodelin as a biomarker of advanced lung adenocarcinoma brain metastases in patients treated with EGFR tyrosine kinase inhibitors

Z Ni, L Zhang, J Zheng, X Su… - Cancer Management and …, 2019 - Taylor & Francis
Objective Brain metastasis (BM) is a serious complication of advanced lung
adenocarcinoma and is a prominent factor leading to lung cancer mortality. In this study, the …

Targeted Delivery of a Novel Conjugate Nef-M1 Peptide and Single-Walled Carbon Nanotubes promotes Growth Inhibition and Mortality for Breast and Colon …

HL Bumpers, JD Goud, U Manne, VR Katkoori - Oncomedicine, 2019 - oncm.org
Abstract The Nef-M1 peptide (Nef-M1) has been shown to be an inhibitor of growth and
metastasis of breast cancer (BC) and colorectal cancer (CRC) cells. Since a nano-construct …

Treatment of C1013G/CXCR4-associated waldenstroöm's macroglobulinemia with an anti-CXCR4 antibody

IM Ghobrial, AM Roccaro, JM Cardarelli… - US Patent …, 2019 - Google Patents
US10233248B2 - Treatment of C1013G/CXCR4-associated waldenstroöm's macroglobulinemia
with an anti-CXCR4 antibody - Google Patents US10233248B2 - Treatment of …

CXCR4 Imaging in Multiple Myeloma

MI Morales, C Lapa, AK Buck - Molecular Imaging in Multiple Myeloma, 2019 - Springer
Abstract The C–X–C chemokine receptor 4 (CXCR4) and its natural ligand CXCL12 are key
factors in the process of cell migration, homing of hematopoietic stem cells to the bone …